Aim: To investigate the relationship between serum levels of tumor necrosis factor-α (TNF-α) and soluble TNF receptor (sTNFR) and bone mineral density (BMD) before and after estrogen– progestogen therapy (EPT).
Introduction Mammographic density (MD) is one of the strongest known breast cancer risk factors. Es...
Osteoarthritis (OA) is a slowly progressive degenerative joint disease of the articular cartilage th...
Post menopause is considered a critical period for bone-mass loss. Impaired bone metabolism during t...
Objective: The aim of the present study was to investigate the relationship of polymorphisms in the ...
Objective: The aim of his study was to investigate the relationship between the circulating tumor ne...
[[abstract]]Osteoporosis is a common disorder with a strong genetic component. We investigated the c...
AbstractObjectiveTo investigate the relationship between single nucleotide polymorphisms (SNPs) of t...
To evaluate the effects of genetic polymorphisms of OPG, RANK, and ESR1, which regulate osteoclastog...
Objective: The purpose of this study was to investigate the association between single nucleotide po...
Summary: The 1p36 region of the human genome has been identified as containing a QTL for BMD in mult...
The aim of this study was to explore the allelic association between genetic polymorphisms of the NF...
Variation in drug response to hormone replacement therapy (HRT) may reflect genetic heterogeneity in...
© Clinical Rheumatology 2007The aim of this study was to identify and evaluate laboratory parameters...
High mammographic density and exposure to sex steroids are independent risk factors for breast cance...
<p>Age, BMI, and residential area were included as covariates in the additive genetic models. Sample...
Introduction Mammographic density (MD) is one of the strongest known breast cancer risk factors. Es...
Osteoarthritis (OA) is a slowly progressive degenerative joint disease of the articular cartilage th...
Post menopause is considered a critical period for bone-mass loss. Impaired bone metabolism during t...
Objective: The aim of the present study was to investigate the relationship of polymorphisms in the ...
Objective: The aim of his study was to investigate the relationship between the circulating tumor ne...
[[abstract]]Osteoporosis is a common disorder with a strong genetic component. We investigated the c...
AbstractObjectiveTo investigate the relationship between single nucleotide polymorphisms (SNPs) of t...
To evaluate the effects of genetic polymorphisms of OPG, RANK, and ESR1, which regulate osteoclastog...
Objective: The purpose of this study was to investigate the association between single nucleotide po...
Summary: The 1p36 region of the human genome has been identified as containing a QTL for BMD in mult...
The aim of this study was to explore the allelic association between genetic polymorphisms of the NF...
Variation in drug response to hormone replacement therapy (HRT) may reflect genetic heterogeneity in...
© Clinical Rheumatology 2007The aim of this study was to identify and evaluate laboratory parameters...
High mammographic density and exposure to sex steroids are independent risk factors for breast cance...
<p>Age, BMI, and residential area were included as covariates in the additive genetic models. Sample...
Introduction Mammographic density (MD) is one of the strongest known breast cancer risk factors. Es...
Osteoarthritis (OA) is a slowly progressive degenerative joint disease of the articular cartilage th...
Post menopause is considered a critical period for bone-mass loss. Impaired bone metabolism during t...
DOI
Add to ORKG